#768 — The Industry Wire

  1. JPM26: Pharma firms tout drug pipeline potential.  
  2. JPM26: OpenEvidence developing “medical super-intelligence.”
  3. JPM26: VC firm holds mobile meetings on crowded SF streets
  4. House votes to revive enhanced ACA subsidies.
  5. Health insurance enrollment lags 2025 sign-ups.
  6. Illumina names former NIH genomics director as CMO.
  7. Senate dings UnitedHealth’s MA risk adjustment policies.
  8. Who should regulate AI in healthcare?
  9. OpenAI acquires healthcare startup Torch for $60M.
  10. Walmart returns to healthcare.
Get every issue of The Imaging Wire, delivered right to your inbox.

You might also like